Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

2018.10.11

Microscopic colitis and ulcerative colitis in focus in Germany

From 12 to 15 September 2018, the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for General and Visceral Surgery (DGAV) held the annual congress Viszeralmedizin in Munich.

With the eyes set on the future, Tillotts Pharma GmbH hosted a satellite workshop on September 15, 2018, addressing topics that are likely to gain importance in gastroenterology:

Microscopic colitis (MC): Nocturnal symptoms are indicative for the most common diagnosis of watery diarrhea”, reported Dr. med. Stefan Shubert, a practicing specialist in internal medicine with a focus on gastroenterology in Berlin, Germany.

In addition, Dr. med. Robert Hofmann, Head of Medicines at Tillotts Pharma AG in Rheinfelden, Switzerland, spoke about "Cost-effective basic therapies for ulcerative colitis".

To read the full report, please click here. (Content is available in German for medical experts with DocCheck registration).

 

						object(WP_Post)#12266 (24) {
  ["ID"]=>
  int(3764)
  ["post_author"]=>
  string(1) "3"
  ["post_date"]=>
  string(19) "2018-10-11 08:40:55"
  ["post_date_gmt"]=>
  string(19) "2018-10-11 07:40:55"
  ["post_content"]=>
  string(1204) "From 12 to 15 September 2018, the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for General and Visceral Surgery (DGAV) held the annual congress Viszeralmedizin in Munich.

With the eyes set on the future, Tillotts Pharma GmbH hosted a satellite workshop on September 15, 2018, addressing topics that are likely to gain importance in gastroenterology:

“Microscopic colitis (MC): Nocturnal symptoms are indicative for the most common diagnosis of watery diarrhea”, reported Dr. med. Stefan Shubert, a practicing specialist in internal medicine with a focus on gastroenterology in Berlin, Germany.

In addition, Dr. med. Robert Hofmann, Head of Medicines at Tillotts Pharma AG in Rheinfelden, Switzerland, spoke about "Cost-effective basic therapies for ulcerative colitis".

To read the full report, please click here. (Content is available in German for medical experts with DocCheck registration).

 "
  ["post_title"]=>
  string(62) "Microscopic colitis and ulcerative colitis in focus in Germany"
  ["post_excerpt"]=>
  string(0) ""
  ["post_status"]=>
  string(7) "publish"
  ["comment_status"]=>
  string(6) "closed"
  ["ping_status"]=>
  string(6) "closed"
  ["post_password"]=>
  string(0) ""
  ["post_name"]=>
  string(62) "microscopic-colitis-and-ulcerative-colitis-in-focus-in-germany"
  ["to_ping"]=>
  string(0) ""
  ["pinged"]=>
  string(0) ""
  ["post_modified"]=>
  string(19) "2020-06-17 15:02:19"
  ["post_modified_gmt"]=>
  string(19) "2020-06-17 14:02:19"
  ["post_content_filtered"]=>
  string(0) ""
  ["post_parent"]=>
  int(0)
  ["guid"]=>
  string(52) "https://www.tillotts.com/?post_type=news&p=3764"
  ["menu_order"]=>
  int(13)
  ["post_type"]=>
  string(4) "news"
  ["post_mime_type"]=>
  string(0) ""
  ["comment_count"]=>
  string(1) "0"
  ["filter"]=>
  string(3) "raw"
}